VNDA

Vanda Pharmaceuticals Inc

Price:

6.12

USD

Volume:

1,422,246.00

United States | Biotechnology

-134.29 %

Upside

As of 2024-06-22, the Fair Value of Vanda Pharmaceuticals Inc (VNDA) is -2.10 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 6.12 USD, the upside of Vanda Pharmaceuticals Inc is -134.29%.

Note: valuation result may not be accurate due to the company's negative EPS.

6.12 USD

Stock Price

-2.10 USD

Fair Price

Peter Lynch's formula is:

VNDA Fair Value

= Earnings Growth Rate x TTM EPS
VNDA Fair Value

= 25.00 x -0.08
VNDA Fair Value

= -2.10
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |

Net income | 115.60 | 23.30 | 33.20 | 6.30 | 2.51 | 36.18 |

YoY growth | 358.73% | -79.84% | 42.49% | -81.02% | -60.17% | 36.04% |

Market Cap (mil) | 356.18 |

P/E | |

Forward P/E | 68.24x |

EPS | -0.08 |

Avg earnings growth rate | 36.04% |

TTM earnings | -4.89 |